Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: Preliminary study

BMC Research Notes

Volumn 1, Issue , 2008, Pages

  Zekri, Abdel Rahman N ^a   Hafez, Mohamed M ^a   Bahnassy, Abeer A ^a   Hassan, Zeinab K ^a   Mansour, Tarek ^a   Kamal, Mahmoud M ^b   Khaled, Hussein M ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL CANCER INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 4;

EID: 77249101159     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-1-106     Document Type: Article

References (36)

1. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108 15761078
2. Molecular features of non-B, non-C hepatocellular carcinoma: a PCRarray gene expression profiling study. Y Kurokawa R Matoba I Takemasa S Nakamori M Tsujie H Nagano K Dono K Umeshita M Sakon N Ueno H Kita S Oba S Ishii K Kato M Monden, Hepatol 2003 39 6 1004 12 10.1016/S0168-8278(03)00473-2 (Pubitemid 37523773)
3. Primary liver cancer: worldwide incidence and trends. FX Bosch J Ribes M Diaz R Cleries, Gastroenterology 2004 127 5 S16 10.1053/j.gastro.2004.09.011 15508102
4. Molecular viral oncology of hepatocellular carcinoma. TM Block AS Mehta CJ Fimmel R Jordan, Oncogene 2003 22 5093 5107 10.1038/sj.onc.1206557 12910247
5. Molecular pathogenesis of human hepatocellular carcinoma. SS Thorgeirsson JW Grisham, Nat Genet 2002 31 339 346 10.1038/ng0802-339 12149612
6. Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis. LH Zhang LX Qin ZC Ma SL Ye YK Liu QH Ye X Wu W Huang ZY Tang, J Cancer Res Clin Oncol 2003 129 279 286 12734753
7. Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma. AR Zekri AA Bahnassy SM Shaarawy OA Mansour MA Maduar HM Khaled O El-Ahmadi, J Med Microbiol 2002 49 1 89 95 10.1016/S0167-7012(01)00353-0 (Pubitemid 34056557)
8. Occult HBV infection and clinical outcomes of Patients with HCV. J-H Kao P-J Chen M-Y Lai D-S Chen, J Clini Microbiology 2000 40 11 4068 4071 10.1128/JCM.40.11.4068-4071.2002
9. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. YH Yang S Dudoit P Luu DM Lin V Peng J Ngai TP Speed, Nucleic Acids Res 2002 30 15 11842121 10.1093/nar/30.4.e15
10. Cluster analysis and display of genome-wide expression patterns. MB Eisen PT Spellman PO Brown D Botstein, Proc Natl Acad Sci USA 95 25 14863 8 9843981 10.1073/pnas.95.25.14863
11. Hepatocellular carcinoma: an epidemiologic view. HB El-Serag, J Clin Gastroenterol 2002 35 Suppl 2 72 7 10.1097/00004836-200211002-00002 (Pubitemid 35278644)
12. A new nomenclature for the laminins. RE Burgeson M Chiquet R Deutzmann P Ekblom J Engel Kleinman GR Martin G Meneguzzi M Paulsson J Sanes, Matrix Biol 1994 14 209 211 10.1016/0945-053X(94)90184-8 7921537
13. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. C Pyke S Salo E Ralfkiaer J Romer K Dano K Tryggvason, Cancer Res 1995 55 4132 4139 7664291
14. Overexpression of laminin 2 chain monomer in invading gastric carcinoma cells. N Koshikawa K Moriyama H Takamura H Mizushima Y Nagashima S Yanoma K Miyazaki, Cancer Res 1999 59 5596 5601 10554040
15. Cooperative interactions of laminin 5 2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. RE Seftor EA Seftor N Koshikawa PS Meltzer LM Gardner M Bilban WG Stetler-Stevenson V Quaranta MJ Hendrix, Cancer Res 2001 61 6322 6327 11522618
16. Wide distribution of laminin-5 -2 chain in basement membranes of various human tissues. H Mizushima N Koshikawa K Moriyama H Takamura Y Nagashima F Hirahara K Miyazaki, Horm Res 1998 50 Suppl 2 7 14 10.1159/000053118 9721586
17. Characterization of a human regulatory subunit of protein phosphatase 3 gene (PPP3RL) expressed specifically in testis. L Liu J Zhang J Yuan Y Dang C Yang X Chen J Xu L Yu, Mol Biol Rep 2005 32 1 41 5 10.1007/s11033-004-4250-4 15865209
18. TGF-bmediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. AM Gressner B Lahme HG Mannherz B Polzar, J Hepatol 1997 26 1079 1092 10.1016/S0168-8278(97)80117-1 9186839
19. Elevated levels of transforming growth factor-b messenger RNA and its polypeptide in human hepatocellular carcinoma. N Ito S Kawata S Tamura 7 other authors, Cancer Res 1991 51 4080 4083 1649698
20. Transforming growth factor-b1 as a useful serologic marker of small hepatocellular carcinoma. BC Song YH Chung JA Kim 7 other authors, Cancer 2002 94 175 180 10.1002/cncr.10170 11815974
21. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. T Yamada AT De Souza S Finkelstein RL Jirtle, Proc Natl Acad Sci USA 1997 94 10351 10355 9294214 10.1073/pnas.94.19.10351 (Pubitemid 27407045)
22. Failure to detect genetic alteration of the mannose-6-phosphate/insulin- like growth factor 2 receptor. I Wada H Kanada K Nomura Y Kato R Machinami T Kitagawa, Hepatology 1999 29 1718 1721 10.1002/hep.510290635 10347113
23. The effect of hepatitis B virus X gene expression on response to growth inhibition by transforming growth factor-b1. O Oshikawa S Tamura S Kawata 7 other authors, Biochem Biophys Res Commun 1996 222 770 773 10.1006/bbrc.1996. 0819 8651920
24. Regulation of transforming growth factor-b1 expression by the hepatitis B virus (HBV) X transactivator. YD Yoo H Ueda K Park KC Flanders YI Lee G Jay SJ Kim, J Clin Invest 1996 97 388 395 8567959 10.1172/JCI118427
25. The hepatitis B virus encoded oncoprotein pX amplifies TGF-b family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. DK Lee SH Park Y Yi 8 other authors, Genes Dev 2001 15 455 466 11230153 10.1101/gad.856201 (Pubitemid 32187006)
26. In vitro and in vivo association of transforming growth factor-b1 with hepatic fibrosis. MJ Czaja FR Weiner KC Flanders MA Giambrone R Wind L Biempica MA Zern, J Cell Biol 1989 108 2477 2482 2500447 10.1083/jcb.108.6.2477
27. Expression of transforming growth factor alpha/epidermal growth factor receptor, hepatocyte growth factor/c-met and acidic fibroblast growth factor/fibroblast growth factor receptors during hepatocarcinogenesis. Z Hu RP Evarts K Fujio N Omori M Omori ER Marsden SS Thorgeirsson, Carcinogenesis 1996 17 5 931 8 10.1093/carcin/17.5.931 8640940
28. Expression of basic fibroblast growth factor and its receptors and their relationship to proliferation of human HCC cell lines. S Ogasawara H Yano A Iemura T Hisaka M Kojiro, Hepatology 1996 24 198 205 10.1002/hep.510240132 8707262
29. Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human HCC. AP Tsou KM Wu TY Tsen CW Chi JH Chiu WY Lui CP Hu C Chang SF Tsai, Genomics 2002 50 331 340 10.1006/geno.1998.5338
30. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. PJ Coopman MT Do M Barth, et al. Nature 2000 406 742 7 10.1038/35021086 10963601
31. Frequent Epigenetic Inactivation of SYK Gene in Human Hepatocellular Carcinoma: An Independent Prognostic Marker. Y Yunfei W Jianping L Jinqing W Li L Meixiang Y Zuli Z Changqing J Le Dai, Clin Cancer Res 12 22 6687 6695 17121887
32. Notch1 Signaling Inhibits Growth of Human Hepatocellular Carcinoma through Induction of Cell Cycle Arrest and Apoptosis. Q Runzi A Huazhang Y Yizhi Z Minghui L Shuxun X Hongmei G Zhenghong C Tao C Xuetao, Cancer Research 2003 63 8323 8329 14678992
33. Interleukin 8 in human hepatocellular carcinoma correlates with cancer cell invasion of vessels but not with tumor angiogenesis. F Kubo S Ueno K Hiwatashi M Sakoda K Kawaida K Nuruki T Aikou, Ann Surg Oncol 2005 12 10 800 7 10.1245/ASO.2005.07.015 16132378
34. Novel human malignancy-associated gene (MAG) expressed in various tumors and in some tumor preexistingconditions. JY Ljubimova SE Wilson LM Petrovic K Ehrenman AV Ljubimov AA Demetriou SA Geller KL Black, Cancer Res 58 19 4475 9 9766681
35. Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling. H Fang W Tong R Perkins L Shi H Hong X Cao Q Xie SH Yim JM Ward HC Pitot YP Dragan, BMC Bioinformatics 2005 6 Suppl 2 6 16026603 10.1186/1471-2105-6-S2-S6 (Pubitemid 41574321)
36. Differentially profiling the low-expression transcriptomes of human hepatoma using a novel SSH/microarray approach. Y-S Pan Y-S Lee Y-L Lee W-C Lee S-Y Hsieh, BMC Genomics 2006 7 131 16737534 10.1186/1471-2164-7-131 (Pubitemid 44121977)